Zehirlenmelerde Ekstrakorporeal Tedavi Yaklaşımları

Ouellet, G., Bouchard, J., Ghannoum, M., & Decker, B. S. (2014, July). Available extracorporeal treatments for poisoning: overview and limitations. In Seminars in dialysis (Vol. 27, No. 4, pp. 342-349).

Ghannoum, M., Hoffman, R. S., Gosselin, S., Nolin, T. D., Lavergne, V., & Roberts, D. M. (2018). Use of extracorporeal treatments in the management of poisonings. Kidney international, 94(4), 682-688.

Ghannoum, M., Roberts, D. M., Hoffman, R. S., Ouellet, G., Roy, L., Decker, B. S., & Bouchard, J. (2014, July). A stepwise approach for the management of poisoning with extracorporeal treatments. In Seminars in Dialysis (Vol. 27, No. 4, pp. 362-370).

Martín-Reyes, G., Toledo-Rojas, R., Torres-de Rueda, Á., Sola-Moyano, E., Blanca-Martos, L., Fuentes-Sánchez, L., ... & García-González, I. (2012). Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma. Nefrología (English Edition), 32(1), 35-43.

Ibrahim, R. B., Liu, C., Cronin, S. M., Murphy, B. C., Cha, R., Swerdlow, P., & Edwards, D. J. (2007). Drug removal by plasmapheresis: an evidence‐based review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 27(11), 1529-1549.

Matzke, G. R. (2002). Status of hemodialysis of drugs in 2002. Journal of Pharmacy Practice, 15(5), 405-418.

De Pont, A. C. J. (2007). Extracorporeal treatment of intoxications. Current opinion in critical care, 13(6), 668-673.

Krisper, P., & Stauber, R. E. (2007). Technology Insight: artificial extracorporeal liver support—how does Prometheus® compare with MARS®?. Nature Clinical Practice Nephrology, 3(5), 267-276.

Kawasaki, C. I., Nishi, R., Uekihara, S., Hayano, S., Kragh-Hansen, U., & Otagiri, M. (2005). How tightly can a drug be bound to a protein and still be removable by charcoal hemoperfusion in overdose cases?. Clinical Toxicology, 43(2), 95-99.

Fertel, B. S., Nelson, L. S., & Goldfarb, D. S. (2010). Extracorporeal removal techniques for the poisoned patient: a review for the intensivist. Journal of intensive care medicine, 25(3), 139-148.

Pond, S. M. (1991). Extracorporeal techniques in the treatment of poisoned patients. Medical journal of Australia, 154(9), 617-622.

Holubek, W. J., Hoffman, R. S., Goldfarb, D. S., & Nelson, L. S. (2008). Use of hemodialysis and hemoperfusion in poisoned patients. Kidney international, 74(10), 1327-1334.

Shannon, M. W. (1997). Comparative efficacy of hemodialysis and hemoperfusion in severe theophylline intoxication. Academic emergency medicine, 4(7), 674-678.

Tyagi, P. K., Winchester, J. F., & Feinfeld, D. A. (2008). Extracorporeal removal of toxins. Kidney international, 74(10), 1231-1233.

Ward, R. A., SCHMIDT, B., Hullin, J., HILLEBRAND, G. F., & Samtleben, W. (2000). A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. Journal of the American Society of Nephrology, 11(12), 2344-2350.

Yamashita, A. C. (2007). Mechanisms of solute and fluid removal in hemodiafiltration. In Hemodiafiltration (Vol. 158, pp. 50-56). Karger Publishers.

Bailey, A. R., Sathianathan, V. J., Chiew, A. L., Paterson, A. D., Chan, B. S., & Arora, S. (2011). Comparison of intermittent haemodialysis, prolonged intermittent renal replacement therapy and continuous renal replacement haemofiltration for lithium toxicity: a case report. Critical Care and Resuscitation, 13(2), 120.

Calello, D. P., Liu, K. D., Wiegand, T. J., Roberts, D. M., Lavergne, V., Gosselin, S., ... & Ghannoum, M. (2015). Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the Extracorporeal Treatments in Poisoning Workgroup. Critical care medicine, 43(8), 1716-1730.

Roberts, D. M., Yates, C., Megarbane, B., Winchester, J. F., Maclaren, R., Gosselin, S., ... & Ghannoum, M. (2015). Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: a systematic review and consensus statement. Critical care medicine, 43(2), 461-472.

Ghannoum, M., Bouchard, J., Nolin, T. D., Ouellet, G., & Roberts, D. M. (2014, July). Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practice. In Seminars in dialysis (Vol. 27, No. 4, pp. 350-361).

RAHMAN, M. H., HAQQIE, S. S., & McGOLDRICK, M. D. (2006). Acute hemolysis with acute renal failure in a patient with valproic acid poisoning treated with charcoal hemoperfusion. Hemodialysis International, 10(3), 256-259.

Szczepiorkowski, Z. M., Winters, J. L., Bandarenko, N., Kim, H. C., Linenberger, M. L., Marques, M. B., ... & Shaz, B. H. (2010). Apheresis Applications Committee of the American Society for Apheresis Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher, 25(3), 83-177.

Schutt, R. C., Ronco, C., & Rosner, M. H. (2012, March). The role of therapeutic plasma exchange in poisonings and intoxications. In Seminars in dialysis (Vol. 25, No. 2, pp. 201-206). Oxford, UK: Blackwell Publishing Ltd.

Jander, S., Bischoff, J., & Woodcock, B. G. (2000). Plasmapheresis in the treatment of Amanita phalloides poisoning: II. A review and recommendations. Therapeutic apheresis, 4(4), 308-312.

PIERGA, J. Y., BEUEZEBOC, P., Dorval, T., Palangie, T., & Pouillart, P. (1992). Favourable outcome after plasmapheresis for vincristine overdose. Lancet (British edition), 340(8812).

Schönermarck, U., & Bosch, T. (2003). Vascular access for apheresis in intensive care patients. Therapeutic Apheresis and Dialysis, 7(2), 215-220.

Manikian, A., Stone, S., Hamilton, R., Foltin, G., Howland, M. A., & Hoffman, R. S. (2002). Exchange transfusion in severe infant salicylism. Veterinary and human toxicology, 44(4), 224-227.

SANCAK, R., KÜCÜKÖDÜK, S., TASDEMIR, H. A., & BELET, N. (1999). Exchange transfusion treatment in a newborn with phenobarbital intoxication. Pediatric emergency care, 15(4), 268-270.

Wittebole, X., & Hantson, P. (2011). Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure. Clinical Toxicology, 49(9), 782-793.

Sen, S., Ratnaraj, N., Davies, N. A., Mookerjee, R. P., Cooper, C. E., Patsalos, P. N., ... & Jalan, R. (2003). Treatment of phenytoin toxicity by the molecular adsorbents recirculating system (MARS). Epilepsia, 44(2), 265-267.

Dichtwald, S., Dahan, E., Adi, N., Moses, A., & Sorkine, P. (2010). Molecular adsorbent recycling system therapy in the treatment of acute valproic acid intoxication. The Israel Medical Association journal: IMAJ, 12(5), 307-308.

Banner, W. (1996). Risks of extracorporeal membrane oxygenation: is there a role for use in the management of the acutely poisoned patient?. Journal of Toxicology: Clinical Toxicology, 34(4), 365-371.

Chyka, P. A. (1996). Benefits of extracorporeal membrane oxygenation for hydrocarbon pneumonitis. Journal of Toxicology: Clinical Toxicology, 34(4), 357-363.

De Lange, D. W., Sikma, M. A., & Meulenbelt, J. (2013). Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clinical Toxicology, 51(5), 385-393.

Ghannoum, M., Bouchard, J., Nolin, T. D., Ouellet, G., & Roberts, D. M. (2014, July). Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practice. In Seminars in dialysis (Vol. 27, No. 4, pp. 350-361).